Dean Liu Fei and Dean Wang Hu were invited to attend the International Retina Summit, where they shared insights on precision diagnosis and treatment of retinal diseases from a global perspective.

Recently, the International Retina Summit 100 Forum (IRS100)・2025 successfully concluded in Changsha, Hunan Province. Co-hosted by Aier Eye Hospital Group and Hunan Eye Care Foundation, the forum gathered over 300 leading ophthalmology experts from five continents. Attendees included industry luminaries such as Academician Yang Xiongli and Academician Yang Zhenglin of the Chinese Academy of Sciences, Academician Fan Xianqun of the Chinese Academy of Engineering, alongside numerous internationally renowned ophthalmology authorities. Under the theme "Focus on Clinical Practice, Integrate Innovation, and Building a Brighter Future."

Aligning with International Frontiers, Strengthening Academic Leadership

The conference featured a Retinal Innovation, Translation, and Investment Forum, keynote speeches, and four parallel forums: “Retinal Surgery,” “Retinal Medicine,” “Basic Research,” and “Future Ophthalmology.” It focused on cutting-edge directions such as gene therapy, artificial intelligence, surgical robotics, and stem cell research, systematically presenting the latest achievements and development trends in retinal medicine from research to clinical practice, contributing a “global solution” for the diagnosis and treatment of retinal diseases.

The Retinal Disease Expert Team from Dongguan Aier Eye Hospital—including Dongguan Regional Director Liu Fei and Wang Hu, Director of Humen Aier Eye Hospital and Director of the Retinal Diseases Department at Dongguan Aier Eye Hospital. Leveraging their department's extensive expertise and academic influence in retinal diseases, they were invited to participate in this high-level international academic gathering. They engaged with global ophthalmic elites to discuss cutting-edge advancements and explore collaborative development, further aligning with international progress in retinal medicine, absorbing innovative concepts, and injecting new momentum into clinical practice.

Aligning with International Frontiers, Strengthening Academic Leadership

The conference features the Retinal Innovation, Translation, and Investment Forum, keynote speeches, and four parallel forums: “Retinal Surgery,” “Retinal Medicine,” “Basic Research,” and “Future Ophthalmology.” Focusing on cutting-edge directions such as gene therapy, artificial intelligence, surgical robotics, and stem cell research, it systematically presents the latest achievements and development trends in retinal medicine from research to clinical practice, contributing a “global solution” for the diagnosis and treatment of retinal diseases.

The Retinal Disease Expert Team from Dongguan Aier Eye Hospital—including Dongguan Regional Director Liu Fei and Wang Hu, Director of Humen Aier Eye Hospital and Director of the Retinal Diseases Department at Dongguan Aier Eye Hospital. Leveraging their department's extensive expertise and academic influence in retinal diseases, they were invited to participate in this high-level international academic gathering. They engaged with global ophthalmic leaders to discuss cutting-edge advancements and collaborative development, further aligning with international progress in retinal medicine, absorbing innovative concepts, and injecting new momentum into clinical practice.

As a globally oriented academic gathering, IRS100 serves not only as a showcase for cutting-edge technologies but also aligns perfectly with Aier Eye Hospital's core strategy of “Innovation-Driven, Technology-Powered Aier.” For years, Aier Eye Hospital has continuously advanced the clinical translation and application of frontier technologies such as AI-assisted diagnosis, gene therapy, and surgical robots, striving for comprehensive upgrades from basic research to clinical practice.

Guided by this vision, the Retinal Diseases Department at Dongguan Aier Eye Hospital actively integrates cutting-edge international technologies with local clinical needs. It has built a medical team combining academic excellence with practical experience, continuously enhancing regional retinal disease diagnosis and treatment standards through the ongoing absorption of global expertise.

As a globally oriented academic gathering, IRS100 serves not only as a showcase for cutting-edge technologies but also aligns closely with Aier Eye Hospital's core strategy of “Innovation-Driven, Technology-Powered Aier.” Over the years, Aier has consistently advanced the clinical translation and application of frontier technologies such as AI-assisted diagnosis, gene therapy, and surgical robotics, striving for comprehensive upgrades from fundamental research to clinical practice.

Guided by this vision, the Retinal Disease Department at Dongguan Aier Eye Hospital actively integrates cutting-edge international technologies with local clinical needs. It has built a medical team combining academic excellence with practical experience, continuously elevating regional retinal disease diagnosis and treatment standards while drawing on global expertise.

Focusing on Specialized Treatment  Fortifying the Defense for Retinal Health

As a key force in retinal disease diagnosis and treatment in Dongguan, the Retinal Disease Department at Dongguan Aier Eye Hospital, under the leadership of Professor Tang Shibo, President Liu Fei, and President Wang Hu, has formed an experienced and highly skilled medical team.

Addressing the complexity and diversity of retinal diseases, the department offers specialized clinics including Diabetic Eye Disease Clinic, High Myopia Retina Clinic, and Uveitis Clinic. It also operates an intravitreal injection center, implementing a precision “specialized treatment for specific diseases” model. Simultaneously, to address the urgency of emergencies like retinal detachment and ocular trauma, the department has activated a “24-Hour Retinal Detachment Emergency Green Channel” and an “Ocular Trauma Emergency Green Channel.” These channels ensure efficient response times, allowing patients to receive treatment within the critical golden period and maximizing the preservation of visual function.

Through extensive clinical practice, the team has developed mature expertise in managing diverse retinal conditions including diabetic retinopathy, high myopia-related retinal pathologies, retinal detachment, retinal vein occlusion, macular degeneration, hereditary eye diseases, and floaters.

Leveraging Aier Eye Hospital's globally shared medical resources and technological platform, the department maintains internationally aligned diagnostic and treatment standards. This enables Dongguan residents to access world-class, one-stop retinal disease care right in their hometown—from precise diagnosis and personalized treatment planning to comprehensive postoperative rehabilitation management—all delivered with professionalism and compassion.

The invitation of Directors Liu Fei and Wang Hu to the International Retina Summit not only signifies the industry's high recognition of Dongguan Aier Eye Hospital's Retina Department in terms of technical strength and academic influence, but also presents a significant opportunity for the department to continuously enhance clinical capabilities and drive technological innovation.

Moving forward, Dongguan Aier Eye Hospital's Retinal Disease Department will steadfastly pursue its “Innovation-Driven, Technology-Powered Aier” strategic direction. Guided by cutting-edge international research, the department will deepen technological innovation and clinical practice, translating global ophthalmic expertise into tangible diagnostic and therapeutic capabilities. Through professional, precise, efficient, and compassionate care, we are committed to safeguarding the visual health and quality of life for every patient.